Related Experiment Video
Updated: May 7, 2026

The Development of Lyophilized Loop-mediated Isothermal Amplification Reagents for the Detection of Coxiella burnetii
Published on: April 18, 2016
Antimicrobial therapies for Q fever
1Centers for Disease Control and Prevention, Mailstop G13, 1600 Clifton Rd. Atlanta, GA 30333, USA +1 404 639 1028 +1 404 718 2116 gkersh@cdc.gov.
Q fever, caused by Coxiella burnetii, presents acutely or chronically. Standard treatment involves doxycycline, with alternatives for specific populations and rare doxycycline resistance.
Area of Science:
- Infectious Diseases
- Bacteriology
- Public Health
Background:
- Q fever is an infectious disease caused by Coxiella burnetii.
- It manifests in acute (febrile illness) and chronic (endocarditis) forms.
- Chronic Q fever can be life-threatening, necessitating prolonged treatment.
Purpose of the Study:
- To summarize current understanding of Q fever.
- To outline standard and alternative therapeutic strategies.
- To address doxycycline resistance and emerging treatments.
Main Methods:
- Review of existing literature on Q fever.
- Analysis of treatment guidelines for acute and chronic forms.
- Evaluation of alternative therapies and antibiotic resistance.
Main Results:
- Acute Q fever typically treated with 2 weeks of doxycycline.
- Chronic Q fever requires 18-24 months of doxycycline plus hydroxychloroquine.
- Alternative treatments include co-trimoxazole, quinolones, rifampin, and macrolides for specific cases.
Conclusions:
- Doxycycline is the primary treatment for Q fever.
- Alternative regimens are crucial for certain patient groups and doxycycline resistance.
- Ongoing research may offer new therapeutic options for Q fever.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Inhibitors of Bacterial DNA Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing

